Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$192.43
+3.4%
$196.75
$153.58
$218.66
$340.40B0.556.04 million shs10.40 million shs
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$48.45
+1.1%
$56.24
$39.35
$63.33
$98.58B0.4112.90 million shs18.57 million shs
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
$797,440.07
+0.2%
$770,937.84
$596,421.02
$808,029.50
$1.15T0.83,052 shs518 shs
Chevron Co. stock logo
CVX
Chevron
$140.09
+1.0%
$151.35
$132.04
$168.96
$246.64B0.937.90 million shs6.70 million shs
General Motors stock logo
GM
General Motors
$47.18
+0.1%
$46.86
$38.96
$61.24
$46.94B1.2713.30 million shs15.24 million shs
The Kroger Co. stock logo
KR
Kroger
$70.37
+0.5%
$66.88
$49.04
$73.63
$46.51B0.65.52 million shs6.52 million shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
+3.48%+13.19%-6.19%+10.03%+20.56%
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
+1.23%-1.02%-19.38%-17.67%+8.03%
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
+0.09%+4.76%+1.03%+13.05%+31.39%
Chevron Co. stock logo
CVX
Chevron
+1.01%+4.74%-15.64%-10.34%-15.55%
General Motors stock logo
GM
General Motors
+0.15%+6.26%+1.13%-5.78%+2.92%
The Kroger Co. stock logo
KR
Kroger
+0.49%-2.86%+5.39%+16.39%+26.82%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AbbVie Inc. stock logo
ABBV
AbbVie
4.6007 of 5 stars
2.44.04.23.92.72.51.3
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
4.5667 of 5 stars
3.23.04.24.02.63.30.0
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
0.7968 of 5 stars
0.00.00.02.12.40.81.3
Chevron Co. stock logo
CVX
Chevron
4.7792 of 5 stars
3.23.05.00.02.62.53.1
General Motors stock logo
GM
General Motors
4.8833 of 5 stars
3.15.02.50.03.23.33.8
The Kroger Co. stock logo
KR
Kroger
4.1367 of 5 stars
2.32.04.21.72.62.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.89
Moderate Buy$211.329.82% Upside
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
2.33
Hold$58.0019.71% Upside
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
0.00
N/AN/AN/A
Chevron Co. stock logo
CVX
Chevron
2.47
Hold$166.0618.54% Upside
General Motors stock logo
GM
General Motors
2.18
Hold$54.8316.22% Upside
The Kroger Co. stock logo
KR
Kroger
2.50
Moderate Buy$66.50-5.50% Downside

Current Analyst Ratings Breakdown

Latest GM, CVX, BRK.A, KR, BMY, and ABBV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/28/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$204.00 ➝ $205.00
4/28/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$241.00 ➝ $250.00
4/25/2025
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
4/23/2025
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$70.00 ➝ $68.00
4/23/2025
Chevron Co. stock logo
CVX
Chevron
Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Sell$156.00 ➝ $124.00
4/23/2025
Chevron Co. stock logo
CVX
Chevron
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$171.00 ➝ $152.00
4/23/2025
General Motors stock logo
GM
General Motors
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$62.00
4/22/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$210.00
4/22/2025
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$55.00 ➝ $55.00
4/22/2025
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$65.00
4/17/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$214.00 ➝ $214.00
(Data available from 4/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$56.33B6.04$14.22 per share13.53$1.90 per share101.28
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$47.64B2.07$5.11 per share9.48$8.08 per share6.00
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
$424.23B2.70$38,063.97 per share20.95$393,011.22 per share2.03
Chevron Co. stock logo
CVX
Chevron
$193.41B1.28$17.45 per share8.03$85.78 per share1.63
General Motors stock logo
GM
General Motors
$187.44B0.25$22.90 per share2.06$65.92 per share0.72
The Kroger Co. stock logo
KR
Kroger
$147.12B0.32$10.98 per share6.41$16.12 per share4.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.28B$2.3580.1813.761.627.59%296.28%12.65%N/A
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
-$8.95B$2.67N/A7.962.07-18.53%13.93%2.46%N/A
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
$96.22B$61,913.9110.74N/A28.89%6.94%3.77%N/A
Chevron Co. stock logo
CVX
Chevron
$17.66B$9.7214.4111.131.468.71%11.44%7.01%5/2/2025 (Estimated)
General Motors stock logo
GM
General Motors
$6.01B$6.157.673.990.673.21%15.29%3.82%4/29/2025 (Estimated)
The Kroger Co. stock logo
KR
Kroger
$2.16B$3.6718.6214.912.851.85%27.73%6.35%6/19/2025 (Estimated)

Latest GM, CVX, BRK.A, KR, BMY, and ABBV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2025Q1 2025
Chevron Co. stock logo
CVX
Chevron
$2.49N/AN/AN/A$49.05 billionN/A
4/29/2025Q1 2025
General Motors stock logo
GM
General Motors
$2.63N/AN/AN/A$42.64 billionN/A
4/25/2025Q1 2025
AbbVie Inc. stock logo
ABBV
AbbVie
$2.40$2.46+$0.06$0.72$12.91 billion$13.34 billion
4/24/2025Q1 2025
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$1.50$1.80+$0.30$1.21$10.77 billion$11.20 billion
3/6/2025Q4 2025
The Kroger Co. stock logo
KR
Kroger
$1.09$1.14+$0.05$0.90$34.96 billion$34.31 billion
2/22/2025Q4 2024
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
N/A$10,102.08N/A$6,508.94N/A$94.92 billion
2/6/2025Q4 2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$1.47$1.67+$0.20$0.04$11.57 billionN/A
1/31/2025Q4 2024
AbbVie Inc. stock logo
ABBV
AbbVie
$2.98$2.16-$0.82-$0.02$14.81 billionN/A
1/31/2025Q4 2024
Chevron Co. stock logo
CVX
Chevron
$2.42$2.06-$0.36$1.84$47.40 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.563.41%+6.04%279.15%53 Years
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$2.485.12%+6.38%92.88%17 Years
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
N/AN/AN/AN/AN/A
Chevron Co. stock logo
CVX
Chevron
$6.844.88%+7.08%70.37%38 Years
General Motors stock logo
GM
General Motors
$0.481.02%N/A7.80%N/A
The Kroger Co. stock logo
KR
Kroger
$1.281.82%+16.08%34.88%19 Years

Latest GM, CVX, BRK.A, KR, BMY, and ABBV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/13/2025
The Kroger Co. stock logo
KR
Kroger
quarterly$0.321.94%5/15/20255/15/20256/1/2025
2/13/2025
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.643.4%4/15/20254/15/20255/15/2025
3/3/2025
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
quarterly$0.624.14%4/4/20254/4/20255/1/2025
1/31/2025
Chevron Co. stock logo
CVX
Chevron
Quarterly$1.714.58%2/14/20252/14/20253/10/2025
2/3/2025
The Kroger Co. stock logo
KR
Kroger
quarterly$0.322%2/14/20252/14/20253/1/2025
1/31/2025
The Kroger Co. stock logo
KR
Kroger
quarterly$0.322.08%3/1/20252/14/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
17.94
0.66
0.55
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
2.90
1.25
1.15
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
N/A
0.30
0.30
Chevron Co. stock logo
CVX
Chevron
0.13
1.07
0.80
General Motors stock logo
GM
General Motors
1.38
1.13
0.98
The Kroger Co. stock logo
KR
Kroger
1.74
1.54
1.07

Institutional Ownership

CompanyInstitutional Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
70.23%
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
76.41%
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
22.97%
Chevron Co. stock logo
CVX
Chevron
72.42%
General Motors stock logo
GM
General Motors
92.67%
The Kroger Co. stock logo
KR
Kroger
80.93%

Insider Ownership

CompanyInsider Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
0.25%
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
0.09%
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
0.39%
Chevron Co. stock logo
CVX
Chevron
0.20%
General Motors stock logo
GM
General Motors
0.72%
The Kroger Co. stock logo
KR
Kroger
1.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
50,0001.77 billion1.76 billionOptionable
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
34,3002.03 billion2.03 billionOptionable
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
372,0001.44 million1.43 millionNot Optionable
Chevron Co. stock logo
CVX
Chevron
43,8001.76 billion1.79 billionOptionable
General Motors stock logo
GM
General Motors
167,000995.00 million987.84 millionOptionable
The Kroger Co. stock logo
KR
Kroger
420,000660.89 million713.48 millionOptionable

Recent News About These Companies

Grocery Workers VS Goliath
Man Sentenced for Fort Wayne Kroger Shooting
3 Soaring Stocks I'd Buy Now With No Hesitation

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AbbVie stock logo

AbbVie NYSE:ABBV

$192.43 +6.37 (+3.42%)
Closing price 04/28/2025 03:59 PM Eastern
Extended Trading
$193.72 +1.29 (+0.67%)
As of 04:31 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Bristol-Myers Squibb stock logo

Bristol-Myers Squibb NYSE:BMY

$48.45 +0.55 (+1.15%)
Closing price 04/28/2025 03:59 PM Eastern
Extended Trading
$48.50 +0.05 (+0.10%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Berkshire Hathaway stock logo

Berkshire Hathaway NYSE:BRK.A

$797,390.04 +1,630.03 (+0.20%)
As of 04/28/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Berkshire Hathaway Inc., through its subsidiaries, engages in the insurance, freight rail transportation, and utility businesses worldwide. It provides property, casualty, life, accident, and health insurance and reinsurance; and operates railroad systems in North America. The company also generates, transmits, stores, and distributes electricity from natural gas, coal, wind, solar, hydro, nuclear, and geothermal sources; operates natural gas distribution and storage facilities, interstate pipelines, liquefied natural gas facilities, and compressor and meter stations; and holds interest in coal mining assets. In addition, the company manufactures boxed chocolates and other confectionery products; specialty chemicals, metal cutting tools, and components for aerospace and power generation applications; and flooring, insulation, roofing and engineered, building and engineered components, paints and coatings, and bricks and masonry products, as well as offers manufactured and site-built home construction, and related lending and financial services; and recreational vehicles, apparel products, jewelry, and custom picture framing products, and alkaline batteries. Further, it manufactures castings, forgings, fasteners/fastener systems, and aerostructures; and seamless pipes, fittings, downhole casing and tubing, and various mill forms. Additionally, the company distributes televisions and information; franchises and services quick service restaurants; distributes electronic components; and offers logistics services, grocery and foodservice distribution services, and professional aviation training and shared aircraft ownership programs. It also retails automobiles; furniture, bedding, and accessories; household appliances, electronics, and computers; jewelry, watches, crystal, china, stemware, flatware, gifts, and collectibles; kitchenware; and motorcycle apparel and equipment. The company was incorporated in 1998 and is headquartered in Omaha, Nebraska.

Chevron stock logo

Chevron NYSE:CVX

$140.09 +1.36 (+0.98%)
Closing price 04/28/2025 03:59 PM Eastern
Extended Trading
$139.44 -0.65 (-0.46%)
As of 04:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant. The Downstream segment refines crude oil into petroleum products; markets crude oil, refined products, and lubricants; manufactures and markets renewable fuels, commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives; and transports crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is headquartered in San Ramon, California.

General Motors stock logo

General Motors NYSE:GM

$47.18 +0.07 (+0.15%)
Closing price 04/28/2025 03:59 PM Eastern
Extended Trading
$47.53 +0.35 (+0.74%)
As of 04:28 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

General Motors Company designs, builds, and sells trucks, crossovers, cars, and automobile parts; and provide software-enabled services and subscriptions worldwide. The company operates through GM North America, GM International, Cruise, and GM Financial segments. It markets its vehicles primarily under the Buick, Cadillac, Chevrolet, GMC, Baojun, and Wuling brand names. In addition, the company sells trucks, crossovers, cars, and automobile parts through retail dealers, and distributors and dealers, as well as to fleet customers, including daily rental car companies, commercial fleet customers, leasing companies, and governments. Further, it offers range of after-sale services through dealer network, such as maintenance, light repairs, collision repairs, vehicle accessories, and extended service warranties. Additionally, the company provides automotive financing; and software-enabled services and subscriptions. General Motors Company was founded in 1908 and is headquartered in Detroit, Michigan.

Kroger stock logo

Kroger NYSE:KR

$70.37 +0.37 (+0.53%)
Closing price 04/28/2025 03:59 PM Eastern
Extended Trading
$70.07 -0.30 (-0.43%)
As of 04:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Kroger Co. operates as a food and drug retailer in the United States. The company operates combination food and drug stores, multi-department stores, marketplace stores, and price impact warehouses. Its combination food and drug stores offer natural food and organic sections, pharmacies, general merchandise, pet centers, fresh seafood, and organic produce; and multi-department stores provide apparel, home fashion and furnishings, outdoor living, electronics, automotive products, and toys. The company's marketplace stores offer full-service grocery, pharmacy, health and beauty care, and perishable goods, as well as general merchandise, including apparel, home goods, and toys; and price impact warehouse stores provide grocery, and health and beauty care items, as well as meat, dairy, baked goods, and fresh produce items. It also manufactures and processes food products for sale in its supermarkets and online; and sells fuel through fuel centers. The Kroger Co. was founded in 1883 and is based in Cincinnati, Ohio.